IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New York Stock Exchange during the 12th Annual IPO Summit with Dr. Greg Verdine, CEO of LifeMine Therapeutics. The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed Biopharma IPOs, novel drugs with risk reductions for organ transplants, “big vision” investors and more.
Watch the full recording below:
About Greg Verdine
https://lifeminetx.com/team/gregory-verdine-ph-d/
About LifeMine Theraputics
https://lifeminetx.com/
Contact:
X/Twitter: @IPOEdge
Instagram: @IPOEdge
